NL-OMON40287尚未招募2 期
Dynamics of Androgen Receptor genomics and transcriptomics after neoadjuvant androgen ablation (DARANA) - DARANA, N14DAR
Antoni van Leeuwenhoek Ziekenhuis0 个研究点目标入组 60 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 尚未招募
- 发起方
- 入组人数
- 60
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1. Men over 18 years of age.
- •2. non-metastasized prostate cancer, visible on transrectal ultrasound or MRI planned for prostatectomy
- •3. Gleason score 7-10
- •4. written informed consent
- •5. WHO performance 0-1
排除标准
- •1. A history of seizures
- •2. Clinically nodal metastases
- •3. Prostatitis or urinary tract infection
- •Androgen ablative therapy within 6 weeks of inclusion (including 5 alpha-reductase inhibitors)
研究者
相似试验
进行中（未招募）
1 期
Dynamics of Androgen Receptor.MedDRA version: 21.1Level: PTClassification code 10036909Term: Prostate cancer metastaticSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036920Term: Prostate cancer stage IVSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 20.0Level: PTClassification code 10060862Term: Prostate cancerSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036911Term: Prostate cancer recurrentSystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036912Term: Prostate cancer stage 0System Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036917Term: Prostate cancer stage ISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036919Term: Prostate cancer stage IIISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)MedDRA version: 21.0Level: PTClassification code 10036918Term: Prostate cancer stage IISystem Organ Class: 10029104 - Neoplasms benign, malignant and unspecified (incl cysts and polyps)Prostate cancerEUCTR2014-000476-26-NLetherlands Cancer Institute50
已完成
2 期
Dynamics of Androgen Receptor Genomics and Transcriptomics After Neoadjuvant Androgen AblationDNAAndrogen Receptor AbnormalProstate CancerNCT03297385The Netherlands Cancer Institute50
招募中
不适用
Androgen Receptor, Implications for Health and Wellbeing: Natural History Study of Individuals With Androgen InsensitivityMetabolic Parameters in AIS, CAIS, PAIS and MAISTumor Formation in AIS, CAIS, PAIS and MAISSexual Function AIS, CAIS, PAIS and MAISAndrogen Insensitivity SyndromeNCT04708431Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD)650
尚未招募
不适用
Detection of aberrant androgen receptor transcripts in circulating tumour cells as a predictor of resistance to AR- directed treatment in patients with castration-resistant prostate cancer.NL-OMON42793niversiteit Antwerpen15
招募中
1 期
Based on Androgen Receptor Gene to Study the Mechanism of Spleen Deficiency Damp-Heat Syndrome Depression with Seborrheic AlopeciaDepressionITMCTR2100004444Tongde Hospital of Zhejiang Province